Robot-Guided Navigation Enhances Precision and Safety in Lung Tumor Ablation

Robot-assisted probe placement during radiofrequency ablation (RFA) procedures could offer a safer and more efficient path forward for patients with inoperable lung tumors, new research suggests. The study, published in the European Journal of Radiology, highlights notable improvements in targeting accuracy, radiation exposure and overall procedural efficiency when robotic navigation systems are employed.

RFA is a widely used treatment for patients who are not candidates for surgical resection. It uses thermal energy to destroy tumor tissue and is especially effective in treating tumors less than 3 centimeters, with control rates approaching 90%. But the technique’s success relies heavily on the experience of the operator, as even small deviations in probe placement can result in incomplete ablation, increasing the risk of complications or recurrence.

“Manual probe placement under imaging guidance demands considerable operator expertise,” explained Dechao Jiao, with the department of interventional radiology at the First Affiliated Hospital of Zhengzhou University in China. “Even in experienced hands, suboptimal probe positioning leads to incomplete ablation margins in 15 to 20 percent of cases. This increases the risk of local recurrence and complications such as bronchopleural fistula or pneumothorax.”

To determine whether robotic navigation could mitigate some of those challenges, researchers compared outcomes for 62 patients with solitary lung tumors who underwent RFA between January 2022 and December 2023. Patients were divided into two cohorts: one group received robot-guided probe placement, and the other underwent a standard manual approach.

The results favored robotic guidance. The team reported significantly improved puncture scoring, shorter puncture times and reduced CT scan durations in the robotic group. Puncture time decreased by an average of three minutes, while CT scan time dropped by nearly two minutes. These efficiencies translated to a notable reduction in radiation exposure—2,215 mGy in the robotic group versus 4,615 mGy in the manual group.

Other metrics such as technical success, total procedure time, rates of local tumor progression and complication rates were similar between both groups. However, the improved targeting accuracy and reduced need for repeated needle adjustments led researchers to recommend robotic navigation as a valuable tool for interventional radiology.

“Our findings demonstrate that robotic navigation significantly enhances targeting accuracy in lung tumors, requiring fewer needle adjustments and intraprocedural CT scans, leading to less radiation exposure compared to manual procedures,” the authors wrote. They attributed the improvements to the system’s real-time compensation for respiratory motion and AI-powered trajectory planning, which helps optimize probe positioning.

As robotic navigation systems continue to integrate advanced imaging and artificial intelligence features, their role in thoracic oncology could expand further. This study offers compelling evidence that such tools may enhance both clinical efficiency and patient safety, especially in complex procedures like RFA.